Victory Capital Management’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.2K Sell
15,223
-1,267
-8% -$3.57K ﹤0.01% 2473
2026
Q2
$51.3K Buy
+16,490
New +$54.2K ﹤0.01% 2395
2024
Q4
– Sell
-629,087
Closed -$2.97M – 2482
2024
Q3
$2.97M Sell
629,087
-5,130
-0.8% -$29.7K ﹤0.01% 1384
2024
Q2
$4.74M Buy
634,217
+262,594
+71% +$3.22M ﹤0.01% 1255
2024
Q1
$6.34M Sell
371,623
-32,304
-8% -$693K 0.01% 1184
2023
Q4
$9.17M Buy
403,927
+337,277
+506% +$5.67M 0.01% 1086
2023
Q3
$1.01M Buy
66,650
+6,980
+12% +$95.4K ﹤0.01% 1647
2023
Q2
$770K Buy
+59,670
New +$648K ﹤0.01% 1799
2022
Q4
– Sell
-42,586
Closed -$28K – 2604
2022
Q3
$28K Sell
42,586
-115
-0.3% -$138 ﹤0.01% 2606
2022
Q2
$45K Buy
42,701
+42
+0.1% +$59 ﹤0.01% 2557
2022
Q1
$59K Sell
42,659
-221,565
-84% -$579K ﹤0.01% 2582
2021
Q4
$1M Buy
264,224
+44,438
+20% +$474K ﹤0.01% 1829
2021
Q3
$2.67M Buy
219,786
+171,529
+355% +$1.58M ﹤0.01% 1495
2021
Q2
$415K Sell
48,257
-2,173
-4% -$21.4K ﹤0.01% 2295
2021
Q1
$560K Sell
50,430
-46
-0.1% -$562 ﹤0.01% 2151
2020
Q4
$630K Sell
50,476
-836
-2% -$10.8K ﹤0.01% 1960
2020
Q3
$556K Sell
51,312
-20,201
-28% -$232K ﹤0.01% 1920
2020
Q2
$797K Sell
71,513
-733
-1% -$5.61K ﹤0.01% 1826
2020
Q1
$527K Sell
72,246
-2,754
-4% -$37.8K ﹤0.01% 1823
2019
Q4
$1.05M Buy
+75,000
New +$889K ﹤0.01% 1739

Other funds holding CABA

Victory Capital Management's CABA Position: Q3 2026 in Review

Victory Capital Management reduced its Cabaletta Bio (CABA) stake by 7.7% in Q3 2026, selling an estimated $3.57K and leaving 15,223 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Victory Capital Management first reported a position in CABA in Q4 2019 and has held it in 20 quarters since. The position peaked at $9.17M in Q4 2023. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Victory Capital Management held 15,223 shares of Cabaletta Bio worth $29.2K as of Q3 2026.
  • Victory Capital Management sold 1,267 Cabaletta Bio shares in Q3 2026, an estimated $3.57K.
  • Cabaletta Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2473 holding.
  • Victory Capital Management first reported a position in Cabaletta Bio in Q4 2019 and has held it in 20 quarters since.
  • Victory Capital Management's Cabaletta Bio position peaked at $9.17M in Q4 2023.
  • 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.